<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="Abstract Despite successful vaccination programs and effective treatments for some" exact="viral" post="infections, humans are still losing the battle with viruses."/>
 <result pre="screening Method Replication Entry Assembly In vitro Cell-based 1 Introduction" exact="Viral" post="pandemics remain serious threats to humankind. Every year, known"/>
 <result pre="to humankind. Every year, known viruses such as HIV-1 and" exact="hepatitis" post="B virus newly infect millions of people across the"/>
 <result pre="In addition, recent outbreaks of Ebola virus, influenza virus, severe" exact="acute" post="respiratory syndrome (SARS) coronavirus and Middle East respiratory syndrome-coronavirus"/>
 <result pre="addition, recent outbreaks of Ebola virus, influenza virus, severe acute" exact="respiratory" post="syndrome (SARS) coronavirus and Middle East respiratory syndrome-coronavirus (MERS-CoV)"/>
 <result pre="recent outbreaks of Ebola virus, influenza virus, severe acute respiratory" exact="syndrome" post="(SARS) coronavirus and Middle East respiratory syndrome-coronavirus (MERS-CoV) serve"/>
 <result pre="virus, severe acute respiratory syndrome (SARS) coronavirus and Middle East" exact="respiratory" post="syndrome-coronavirus (MERS-CoV) serve as a reminder of the silent"/>
 <result pre="that over 1.34 million causalities per year are connected with" exact="hepatitis" post="B and almost 500,000 with hepatitis C. Occasional epidemic"/>
 <result pre="year are connected with hepatitis B and almost 500,000 with" exact="hepatitis" post="C. Occasional epidemic outbreaks of other viruses are also"/>
 <result pre="problems. Unlike cellular genomes, which consist of double-stranded (ds) DNA," exact="viral" post="genomes can be formed by a broad variety of"/>
 <result pre="linear DNA or positive-, negative- or sometimes ambi-sense RNA. As" exact="viral" post="life cycles are dependent on cellular factors and cellular"/>
 <result pre="drug development efforts is to design compounds that specifically inhibit" exact="viral" post="targets or cellular targets essential for virus replication. The"/>
 <result pre="1.1 Morphology To package their genomes into particles of very" exact="limited" post="size, viruses encode few genes. Virions consist of an"/>
 <result pre="capsid is additionally surrounded by a lipid bilayer spiked with" exact="viral" post="proteins. The size of animal viruses ranges from approximately"/>
 <result pre="The capsids and virions of RNA viruses adopt various shapes." exact="Viral" post="capsids may be icosahedral (e.g. Picornaviridae, Astroviridae, Reoviridae, Togaviridae),"/>
 <result pre="retroviral capsid core may be conical, spherical, or rod-shaped. The" exact="morphology" post="of DNA viruses is similarly diverse, ranging from icosahedral"/>
 <result pre="Papillomaviridae) to rod-shaped (Baculoviridae) or pleomorphic (Poxviridae). 1.2 Structure The" exact="viral" post="life cycle is the process of viral replication in"/>
 <result pre="1.2 Structure The viral life cycle is the process of" exact="viral" post="replication in a host cell. First, viruses enter the"/>
 <result pre="the host cell and replicate their genomes. Following translation of" exact="viral" post="proteins by the host cell machinery, viruses package their"/>
 <result pre="viruses consist only of a protein capsid shell enclosing the" exact="viral" post="genome and enzymes, while the capsid shell of enveloped"/>
 <result pre="and attachment. For example, they may enable fusion of the" exact="viral" post="and cellular membranes, usually through an interaction with a"/>
 <result pre="viral and cellular membranes, usually through an interaction with a" exact="secondary" post="receptor(s) or co-receptor(s). The fusion domains of viral surface"/>
 <result pre="with a secondary receptor(s) or co-receptor(s). The fusion domains of" exact="viral" post="surface glycoproteins thus can lower the kinetic barrier for"/>
 <result pre="co-receptor(s). The fusion domains of viral surface glycoproteins thus can" exact="lower" post="the kinetic barrier for the energetically demanding membrane fusion."/>
 <result pre="the kinetic barrier for the energetically demanding membrane fusion. The" exact="viral" post="particle must be sufficiently stable to protect the genome"/>
 <result pre="energetically demanding membrane fusion. The viral particle must be sufficiently" exact="stable" post="to protect the genome until its delivery into the"/>
 <result pre="cell at the appropriate time. The energetic barrier that prevents" exact="viral" post="disassembly outside the cell is lowered upon infection by"/>
 <result pre="that prevents viral disassembly outside the cell is lowered upon" exact="infection" post="by structural changes in the viral components. These changes"/>
 <result pre="cell is lowered upon infection by structural changes in the" exact="viral" post="components. These changes may be induced by binding of"/>
 <result pre="undergo irreversible (usually proteolytic) transitions into mature structures of fully" exact="infectious" post="virions. Mutual interactions of viral capsid proteins are typically"/>
 <result pre="into mature structures of fully infectious virions. Mutual interactions of" exact="viral" post="capsid proteins are typically different from those of cellular"/>
 <result pre="from those of cellular proteins, which predominantly create binary interactions." exact="Viral" post="structural proteins interact with multiple neighboring partners to form"/>
 <result pre="2015, Jayaraman et al., 2016)]. The economy of the packaged" exact="viral" post="genomes due to the limited capsid size implies formation"/>
 <result pre="The economy of the packaged viral genomes due to the" exact="limited" post="capsid size implies formation of only a few types"/>
 <result pre="2012, Raguram et al., 2017)]. 2 Common stages in the" exact="viral" post="life cycle In the initial stage of infection, viruses"/>
 <result pre="by the size of the particle and its structure. The" exact="viral" post="life cycle can be divided into several common stages,"/>
 <result pre="1 ). Fig. 1 Simplified scheme of common stages of" exact="viral" post="life cycle targeted by antiviral drugs. These stages including:"/>
 <result pre="uncoating, 3) genome replication, 4) genome packaging and assembly of" exact="viral" post="particle and 5) virus release and maturation. 2.1 Entry"/>
 <result pre="Entry into the cell In general, the first phase of" exact="viral infection" post="is specific recognition of the target host cell and"/>
 <result pre="into the cell In general, the first phase of viral" exact="infection" post="is specific recognition of the target host cell and"/>
 <result pre="nonenveloped viruses. In enveloped viruses, the binding is mediated by" exact="viral" post="surface components, typically oligomers of integral glycoproteins. Nonenveloped viruses"/>
 <result pre="Viruses can use either a single receptor (e.g. TIM-1 for" exact="hepatitis" post="A virus, GM1 for SV40, CD155 for poliovirus, low-density"/>
 <result pre="multiple receptors with equivalent roles (e.g., Nectin-1/2 or HVEM for" exact="herpes" post="simplex virus 1/2, ACE or L-SIGN for SARS coronavirus)."/>
 <result pre="membrane components is required. For example, HIV-1 binds to the" exact="primary" post="receptor CD4 and one of two co-receptors (CCR5 or"/>
 <result pre="or lipid raft-mediated (e.g. SV40, polyomavirus mouse), or macropinocytosis (e.g." exact="vaccinia" post="virus, respiratory syncytial virus, Ebola virus, HIV-1) (Blaas, 2016,"/>
 <result pre="raft-mediated (e.g. SV40, polyomavirus mouse), or macropinocytosis (e.g. vaccinia virus," exact="respiratory" post="syncytial virus, Ebola virus, HIV-1) (Blaas, 2016, Cossart and"/>
 <result pre="surface receptor binding, infect the cell by direct fusion of" exact="viral" post="and plasma membranes at neutral pH. Upon internalization, most"/>
 <result pre="these events can occur in early endosomes (pH 6.5–6.0; e.g." exact="hepatitis" post="C virus, vesicular stomatitis virus), late endosomes (pH 6.0–5.0;"/>
 <result pre="in early endosomes (pH 6.5–6.0; e.g. hepatitis C virus, vesicular" exact="stomatitis" post="virus), late endosomes (pH 6.0–5.0; e.g. influenza A virus,"/>
 <result pre="penetration mechanisms occurs through conformational changes and structural rearrangements in" exact="viral" post="surface proteins and/or the whole virion shell that may"/>
 <result pre="core. Structural rearrangements in enveloped viruses usually mediate fusion of" exact="viral" post="and endosomal membranes. In nonenveloped viruses, the structural changes"/>
 <result pre="genetic material to the replication site, these mechanisms ultimately release" exact="viral" post="capsid structures from endosomal vesicles into the cytosol either"/>
 <result pre="the endosomal membrane (nonenveloped viruses). 2.2 Uncoating Uncoating is the" exact="partial" post="or complete disassembly of the protective capsid shell and/or"/>
 <result pre="membrane (nonenveloped viruses). 2.2 Uncoating Uncoating is the partial or" exact="complete" post="disassembly of the protective capsid shell and/or lipid envelope"/>
 <result pre="the protective capsid shell and/or lipid envelope to liberate the" exact="viral" post="genome. For many viruses, this process is closely connected"/>
 <result pre="factors. For enveloped viruses, uncoating involves a loss of the" exact="viral" post="membrane by fusion either with the plasma membrane or"/>
 <result pre="karyopherins) (Cautain et al., 2015). Due to the diversity of" exact="viral" post="particle sizes (from 25 nm to over 300 nm)"/>
 <result pre="mechanisms. Due to size limitations, only a few, very small" exact="viral" post="capsid particles, such as hepatitis B virus (HBV; 32–36"/>
 <result pre="only a few, very small viral capsid particles, such as" exact="hepatitis" post="B virus (HBV; 32–36 nm diameter), can pass through"/>
 <result pre="influenza A virus and HIV-1, disassemble within the cytoplasm. The" exact="viral" post="genome, released from the shell and complexed with NLS-containing"/>
 <result pre="Panté, 2015, Hutchinson and Fodor, 2013). Another mechanism, used by" exact="herpes" post="simplex virus (HSV) and adenoviruses, involves cellular (importins, Nup)"/>
 <result pre="simplex virus (HSV) and adenoviruses, involves cellular (importins, Nup) or" exact="viral" post="protein-mediated attachment (docking) of the capsid shell at the"/>
 <result pre="intact particle (through the capsid portal in HSV-1) or upon" exact="complete" post="disassembly of the capsid shell (in adenoviruses) (Kremer and"/>
 <result pre="Roe et al., 1993). Another mechanism, described for parvoviruses, involves" exact="partial" post="disruption of the nuclear envelope (Cohen and Pante, 2005,"/>
 <result pre="(Cohen and Pante, 2005, Fay and Panté, 2015). 2.4 Replication" exact="Viral" post="genomes can be encoded by various types of NAs,"/>
 <result pre="family DNA type/topology Polarity Enzyme Intracellular site Adenoviridae ds/linear Both" exact="Viral" post="DNA polymerase Nucleus Anelloviridae ss/circular (−) Cellular DNA polymerase"/>
 <result pre="Anelloviridae ss/circular (−) Cellular DNA polymerase Nucleus Asfarviridae ds/linear Both" exact="Viral" post="DNA polymerase Cytoplasm Circoviridae ss/circular (−) or ambisense Cellular"/>
 <result pre="(−) or ambisense Cellular DNA polymerase Nucleus Hepadnaviridae ds/linear Both" exact="Viral" post="reverse transcriptase Nucleus/cytoplasm Herpesviridae ds/linear Both Viral DNA polymerase"/>
 <result pre="Hepadnaviridae ds/linear Both Viral reverse transcriptase Nucleus/cytoplasm Herpesviridae ds/linear Both" exact="Viral" post="DNA polymerase Nucleus Iridoviridae ds/linear Both Viral DNA polymerase"/>
 <result pre="Herpesviridae ds/linear Both Viral DNA polymerase Nucleus Iridoviridae ds/linear Both" exact="Viral" post="DNA polymerase Nucleus/cytoplasm Papillomaviridae ds/circular Both Cellular DNA polymerase"/>
 <result pre="DNA polymerase Nucleus/cytoplasm Papillomaviridae ds/circular Both Cellular DNA polymerase Nucleus" exact="Parvoviridae" post="ss/linear Either Cellular DNA polymerase Nucleus Polyomaviridae ds/circular Both"/>
 <result pre="Polyomaviridae ds/circular Both Cellular DNA polymerase Nucleus Poxviridae ds/linear Both" exact="Viral" post="DNA polymerase Cytoplasm Table 2 Basic characteristics of RNA"/>
 <result pre="Arenaviridae ssRNA/2/linear Ambisense Virion RNA polymerase Cytoplasm Arteriviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Astroviridae ssRNA/1/linear (+) Viral RNA polymerase"/>
 <result pre="Arteriviridae ssRNA/1/linear (+) Viral RNA polymerase Cytoplasm Astroviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Birnaviridae dsRNA/2/linear both Virion RNA polymerase"/>
 <result pre="(−) or ambisense Virion RNA polymerase Cytoplasm Caliciviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Coronaviridae ssRNA/1/linear (+) Viral RNA polymerase"/>
 <result pre="Caliciviridae ssRNA/1/linear (+) Viral RNA polymerase Cytoplasm Coronaviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Deltavirus ssRNA/1/circular (−) RNA polymerase II"/>
 <result pre="Filoviridae ssRNA/1/linear (−) Virion RNA polymerase Cytoplasm Flaviviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Hepeviridae ssRNA/1/linear (+) Viral RNA polymerase"/>
 <result pre="Flaviviridae ssRNA/1/linear (+) Viral RNA polymerase Cytoplasm Hepeviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Nodaviridae ssRNA/2/linear (+) Viral RNA polymerase"/>
 <result pre="Hepeviridae ssRNA/1/linear (+) Viral RNA polymerase Cytoplasm Nodaviridae ssRNA/2/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Orthomyxoviridae ssRNA/6-8/linear (−) Virion RNA polymerase"/>
 <result pre="Paramyxoviridae ssRNA/1/linear (−) Virion RNA polymerase Cytoplasm Picornaviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm Reoviridae dsRNA/10-12/linear both Virion RNA polymerase"/>
 <result pre="RNA polymerase Cytoplasm Picornaviridae ssRNA/1/linear (+) Viral RNA polymerase Cytoplasm" exact="Reoviridae" post="dsRNA/10-12/linear both Virion RNA polymerase Cytoplasm Retroviridae ssRNA/2/linear (+)"/>
 <result pre="Rhabdoviridae ssRNA/1/linear (−) Virion RNA polymerase Cytoplasm Togaviridae ssRNA/1/linear (+)" exact="Viral" post="RNA polymerase Cytoplasm 2.4.1 Replication of RNA viruses RNA"/>
 <result pre="template provides (+)RNA that serves as mRNA for translation of" exact="viral" post="proteins. In dsRNA viruses, the (+)RNA is packaged into"/>
 <result pre="either through secretion or cell lysis. C: Following fusion of" exact="viral" post="and cell plasma membrane, the retroviral core is released"/>
 <result pre="released into cytosol, RNA genome is transcribed into dsDNA by" exact="viral" post="reverse transcriptase concomitantly with uncoating of the viral core,"/>
 <result pre="dsDNA by viral reverse transcriptase concomitantly with uncoating of the" exact="viral" post="core, ds DNA is transferred into nucleus where it"/>
 <result pre="nucleus where it is integrated into host cell genome by" exact="viral" post="integrase, following translation of retroviral structural and enzymatic polyproteins,"/>
 <result pre="particles that usually assemble at the plasma membrane and the" exact="viral" post="particles bud from the cell. D: Three mechanisms (I.-III.)"/>
 <result pre="early genes (regulatory proteins, transcription factors) regulate the synthesis of" exact="viral" post="enzymes (e.g. DNA polymerase) required for genome replication; expression"/>
 <result pre="leave the cell (e.g. Herpesviruses). (II) unique replication cycle of" exact="Hepatitis" post="B virus (HBV): following entry, the viral particle is"/>
 <result pre="replication cycle of Hepatitis B virus (HBV): following entry, the" exact="viral" post="particle is internalized by endocytosis and the nucleocapsid is"/>
 <result pre="RNA (pgRNA) for translation of the core protein and the" exact="viral" post="polymerase and three subgenomic mRNAs used for translation of"/>
 <result pre="mRNAs used for translation of regulatory and envelope proteins; following" exact="viral" post="transcription and translation, the HBV core proteins self-assemble in"/>
 <result pre="translation, the HBV core proteins self-assemble in the cytoplasm into" exact="viral" post="nucleocapsid with concurrent incorporation of pgRNA and HBV polymerase,"/>
 <result pre="(+)RNA viruses may serve directly as mRNA for production of" exact="viral" post="proteins. Therefore, the mere introduction of genetic material (e.g."/>
 <result pre="each segment is transcribed in an autonomous transcription-replication unit by" exact="viral" post="RNA polymerase that binds to the 5′ end cap"/>
 <result pre="cap is cleaved from cellular mRNA and transferred onto the" exact="viral" post="gRNA by a subunit of viral RNA polymerase (Pflug"/>
 <result pre="and transferred onto the viral gRNA by a subunit of" exact="viral" post="RNA polymerase (Pflug et al., 2017). Some dsRNA viruses"/>
 <result pre="necessity for some viruses to encode specific proteins required for" exact="viral" post="replication. Small-genome DNA viruses (polyoma-, papilloma-, and parvoviruses) use"/>
 <result pre="replication and transcription. The only exceptions are some hepadnaviruses (e.g." exact="hepatitis" post="B virus) that despite having small genomes (approximately 3"/>
 <result pre="polymerase/reverse transcriptase that reverse transcribes pregenomic RNA (pgRNA) into genomic" exact="viral" post="DNA (Fig. 2D, II) (Beck and Nassal, 2007). Viruses"/>
 <result pre="and several transcription factors (Boehmer and Nimonkar, 2003). Poxviruses (e.g." exact="vaccinia" post="virus), are another type of virus with large dsDNA"/>
 <result pre="of the cell cycle (e.g. parvoviruses), or must express some" exact="viral" post="protein/oncogene to re-program the host cell-cycle regulatory proteins p53"/>
 <result pre="protein/oncogene to re-program the host cell-cycle regulatory proteins p53 or" exact="retinoblastoma" post="protein (pRb), triggering entry into the S-phase (e.g. polyomaviruses"/>
 <result pre="the viruses ensure the production of host enzymes required for" exact="viral" post="replication (Fields and Knipe, 2013). Production of viral proteins"/>
 <result pre="required for viral replication (Fields and Knipe, 2013). Production of" exact="viral" post="proteins of DNA viruses with intermediate and large size"/>
 <result pre="Knipe, 2013). Production of viral proteins of DNA viruses with" exact="intermediate" post="and large size genomes is divided into early and"/>
 <result pre="late structural proteins needed for assembly are translated, begins after" exact="viral" post="DNA replication (Fig. 2D, I). 2.5 Assembly Depending on"/>
 <result pre="exported to the cytoplasm, where they come together to form" exact="viral" post="particles. Nuclear export is specific and depends on the"/>
 <result pre="and San Martín, 2017). The assembly occurs in the so-called" exact="peripheral" post="replicative zone with the assistance of scaffolding proteins that"/>
 <result pre="pass through the NPC, but it exits the nucleus by" exact="viral" post="protein-driven vesicular transport across the nuclear inner membrane leaflet."/>
 <result pre="Final herpesvirus envelopment occurs at the Golgi membrane containing the" exact="viral" post="glycoproteins (Fields and Knipe, 2013). Preassembled orthomyxoviral ribonucleoproteins, upon"/>
 <result pre="even more complicated pathway. They are enveloped with multiple membranes" exact="acquired" post="from ER/intermediate compartments and Golgi or early endosomes (Moss,"/>
 <result pre="TGN. Some viruses, such as coronaviruses, assemble at the ER–Golgi" exact="intermediate" post="compartment [reviewed in (Ujike and Taguchi, 2015)]. The assembly"/>
 <result pre="subsequent glycosylation in the Golgi. Usually, a specific interaction between" exact="viral" post="structural proteins and glycoproteins is required. This may be"/>
 <result pre="virus production. Various types of vesicles that are formed upon" exact="viral infection" post="have different roles in viral replication (Rossignol et al.,"/>
 <result pre="production. Various types of vesicles that are formed upon viral" exact="infection" post="have different roles in viral replication (Rossignol et al.,"/>
 <result pre="that are formed upon viral infection have different roles in" exact="viral" post="replication (Rossignol et al., 2015). Some nonenveloped mammalian viruses,"/>
 <result pre="as reoviruses, assemble in the cytosol in so-called viroplasms or" exact="viral" post="factories into icosahedral particles consisting of three concentric layers"/>
 <result pre="from polyprotein precursors that must be specifically cleaved by a" exact="viral" post="protease to generate infectious particles. This mechanism, which is"/>
 <result pre="must be specifically cleaved by a viral protease to generate" exact="infectious" post="particles. This mechanism, which is an irreversible step in"/>
 <result pre="ensures equimolar packaging of structural proteins and proportional co-assembly of" exact="viral" post="enzymes in the form of precursors. Upon proteolytic release,"/>
 <result pre="for intracellular assembly of immature particles to those suitable for" exact="viral" post="stability in the environment and for disassembly and uncoating"/>
 <result pre="(Veesler and Johnson, 2012)]. In poliovirus, the autocatalytic and subsequent" exact="viral" post="protease-mediated cleavage of P1 precursor protein allows formation of"/>
 <result pre="of VP0, yielding VP2 and VP4, is required to form" exact="infectious" post="poliovirus particles. In retroviruses, proteolytic processing is initiated by"/>
 <result pre="retroviruses, proteolytic processing is initiated by the autocatalytic liberation of" exact="viral" post="protease, which subsequently cleaves the polyproteins to trigger major"/>
 <result pre="major structural rearrangements in the virus and release of other" exact="viral" post="enzymes (reverse transcriptase and integrase) and structural proteins. In"/>
 <result pre="flaviviral particle. This is connected with the exposure of a" exact="viral" post="structural glycoprotein (prM) that is specifically processed by the"/>
 <result pre="simplest release mechanism, although the transition to lysis from latent" exact="infection" post="is delicately regulated (Aneja and Yuan, 2017, Levings and"/>
 <result pre="Jackson et al., 2005), coxsackievirus (Alirezaei et al., 2012), and" exact="hepatitis" post="A virus (Feng et al., 2013). Another possibility is"/>
 <result pre="released from a cell infected with (+)RNA viruses contain naked" exact="viral" post="gRNA. This (+)gRNA-containing vesicle functions itself as an infectious"/>
 <result pre="infected with (+)RNA viruses contain naked viral gRNA. This (+)gRNA-containing" exact="vesicle" post="functions itself as an infectious agent as it is"/>
 <result pre="naked viral gRNA. This (+)gRNA-containing vesicle functions itself as an" exact="infectious" post="agent as it is transferred to another cell (Bird"/>
 <result pre="is budding, which includes membrane extrusion and separation of the" exact="viral" post="and cellular membranes (so-called pinching off). The lipid envelope"/>
 <result pre="and cellular membranes (so-called pinching off). The lipid envelope layer" exact="acquired" post="during viral particle budding through the plasma membrane protects"/>
 <result pre="membranes (so-called pinching off). The lipid envelope layer acquired during" exact="viral" post="particle budding through the plasma membrane protects the virus"/>
 <result pre="protein of coronaviruses; ii) independent of glycoproteins, in which the" exact="viral" post="structural proteins trigger the extrusion of the plasma membrane,"/>
 <result pre="bulging of the membrane; and iii) requiring interaction between the" exact="viral" post="glycoproteins and the capsid for membrane extrusion, as in"/>
 <result pre="the particle. This is a controlled process that involves both" exact="viral" post="protein domains and cellular factors. During this process, viruses"/>
 <result pre="Carlton, 2016, Scourfield and Martin-Serrano, 2017)]. Direct interactions of numerous" exact="viral" post="domains with ESCRT complex subunits have been identified (Bieniasz,"/>
 <result pre="ESCRT complex subunits have been identified (Bieniasz, 2006). In retroviruses," exact="short" post="specific amino acid sequences (PTAP or PSAP) interact with"/>
 <result pre="Interactions with ESCRT proteins have also been reported for vesicular" exact="stomatitis" post="virus (Chen et al., 2010, Luyet et al., 2008),"/>
 <result pre="(Feng et al., 2013), paramyxoviruses (Park et al., 2016), and" exact="hepatitis" post="C virus, a representative of the flavivirus family (Falcon"/>
 <result pre="by viruses may vary under some conditions. For example, during" exact="chronic" post="infection, numerous viruses use alternative cell-to-cell transmission that may"/>
 <result pre="(Hübner et al., 2009, Wang et al., 2017) and murine" exact="leukemia" post="virus (Sherer et al., 2010). Receptors on tight junctions"/>
 <result pre="et al., 2010). Receptors on tight junctions that specifically recognize" exact="hepatitis" post="C virus (Carloni et al., 2012, Ploss et al.,"/>
 <result pre="3 Methods Among the plethora of compounds designed to inhibit" exact="infectious" post="viruses, only a few (&amp;lt; 100) have been approved"/>
 <result pre="herpesviruses. Its remarkable specificity is connected with its activation by" exact="viral" post="thymidine kinase-catalyzed phosphorylation. However, due to development of drug"/>
 <result pre="design and test new inhibitors, preferably targeting different steps of" exact="viral" post="life cycles. Here, we provide insights into the world"/>
 <result pre="were developed to test antivirotics targeting various steps in the" exact="viral" post="life cycle. 3.1 Assays and methods for screening and"/>
 <result pre="life cycle. 3.1 Assays and methods for screening and evaluating" exact="viral" post="entry inhibitors Different types of assays, including cell-cell fusion"/>
 <result pre="assays, including cell-cell fusion assays, cell-virus fusion assays with pseudotyped" exact="viral" post="particles, and in vitro biochemical assays have been developed"/>
 <result pre="vitro biochemical assays have been developed to screen inhibitors of" exact="viral" post="entry. In enveloped viruses, entry is initiated by fusion"/>
 <result pre="In enveloped viruses, entry is initiated by fusion of the" exact="viral" post="envelope with the target cellular membrane. The entry mechanism"/>
 <result pre="triggers a refolding of gp41 that promotes fusion of the" exact="viral" post="and cellular membranes. The refolding involves oligomerization of the"/>
 <result pre="et al., 2003). Cell-based assays are routinely used to screen" exact="viral" post="entry inhibitors. High throughput formats have been developed for"/>
 <result pre="al., 2005). Tscherne et al. developed an approach to monitor" exact="viral" post="entry using the BlaM reporter (Tscherne et al., 2010)."/>
 <result pre="and firefly luciferase and the second encodes a control, unrelated" exact="viral" post="envelope protein and Renilla luciferase. Reporter expression is determined"/>
 <result pre="against entry of both Marburg and Ebola viruses in human" exact="cancer" post="cell lines, and confirmed their anti-Ebola activity in human"/>
 <result pre="cancer cell lines, and confirmed their anti-Ebola activity in human" exact="primary" post="cells (Cheng et al., 2017). Other pseudotyped viral assays"/>
 <result pre="in human primary cells (Cheng et al., 2017). Other pseudotyped" exact="viral" post="assays have been used to screen entry inhibitors of"/>
 <result pre="in identification of several inhibitors that block the cleavage of" exact="viral" post="glycoprotein but not CatL itself (Elshabrawy et al., 2014)."/>
 <result pre="2014). Until recently, the development of anti-HBV therapeutics had been" exact="limited" post="by the lack of an in vitro infection system."/>
 <result pre="had been limited by the lack of an in vitro" exact="infection" post="system. Several aspects of the HBV life cycle have"/>
 <result pre="for HTS of inhibitors (Yan et al., 2012). In an" exact="infection" post="competition assay, HBV particles were isolated and used to"/>
 <result pre="potential activity to block HBV infection. Twelve days after infection," exact="viral" post="RNAs were quantified by Northern blot (Gripon et al.,"/>
 <result pre="into HepaRG and PHHs cell lines (Gripon et al., 2005)," exact="primary" post="cultures of tupaia hepatocytes (Glebe et al., 2005), and"/>
 <result pre="Development of cell culture systems producing HCV pseudoparticles (HCVpp) and" exact="infectious" post="HCV particles (HCVcc) has shed light on HCV interactions"/>
 <result pre="2010). Production of HCVcc is a robust system to generate" exact="infectious" post="HCV in naïve cells (Kato et al., 2006, Zhong"/>
 <result pre="(Gastaminza et al., 2010). 3.2 Assays and methods for screening" exact="viral" post="capsid disassembly/uncoating inhibitors The majority of viruses enter cells"/>
 <result pre="handling, making it difficult to study early steps in the" exact="viral" post="life cycle such as uncoating and capsid disassembly. Viruses"/>
 <result pre="of released HIV-1 virions through a detergent layer, where the" exact="viral" post="membrane dissolves, into a sucrose gradient, where the viral"/>
 <result pre="the viral membrane dissolves, into a sucrose gradient, where the" exact="viral" post="cores are concentrated (Shah and Aiken, 2011). The &quot;fate"/>
 <result pre="HIV-1 core from a whole cell lysate prepared shortly after" exact="infection" post="(Stremlau et al., 2006). The &quot;CsA-washout assay&quot; involves specific"/>
 <result pre="&quot;CsA-washout assay&quot; involves specific cellular factors (TRIM-cyclophilin) that restrict HIV-1" exact="infection" post="by binding to the capsid core and cyclosporine A"/>
 <result pre="of the gradient, which dissolves the membrane to release the" exact="viral" post="core. Moreover, modification of the detergent-containing glycerol layer—for example,"/>
 <result pre="example, by lowering pH, changing ionic strength, or adding putative" exact="viral" post="uncoating factors—enables study of the factors or compounds that"/>
 <result pre="uncoating factors—enables study of the factors or compounds that affect" exact="viral" post="uncoating in vitro. 3.3 Assays and methods for screening"/>
 <result pre="in vitro. 3.3 Assays and methods for screening and evaluating" exact="viral" post="genome replication inhibitors 3.3.1 Polymerases Depending on the virus"/>
 <result pre="the virus type, either DNA or RNA polymerases replicate the" exact="viral" post="genome. Thus, these enzymes play a key role in"/>
 <result pre="viral genome. Thus, these enzymes play a key role in" exact="viral" post="life cycles. Reverse transcriptase, an RNA-dependent DNA polymerase of"/>
 <result pre="unique among nucleic acid polymerases. Despite the different mechanisms of" exact="viral" post="replication, polymerases, which are essential for all viruses, are"/>
 <result pre="real-time reverse-transcription PCR has become standard for screening inhibitors of" exact="viral" post="RNA polymerases (Lee et al., 2015, Okon et al.,"/>
 <result pre="of poliovirus RNA polymerase (Campagnola et al., 2011). When available," exact="viral" post="genomes modified with reporter genes can be used for"/>
 <result pre="can be used for cell-based luminescent or fluorescent screening of" exact="viral" post="inhibitors (Beadle et al., 2016, Edwards et al., 2015,"/>
 <result pre="been developed (Ranjith-Kumar et al., 2011). The RIG-I-like receptors are" exact="cytosolic" post="proteins that recognize viral RNA and induce production of"/>
 <result pre="al., 2011). The RIG-I-like receptors are cytosolic proteins that recognize" exact="viral" post="RNA and induce production of proinflammatory cytokines and interferon-activated"/>
 <result pre="and Thomsen, 2012). RIG-I triggers cytokine production stimulated by various" exact="viral" post="RNAs from different families, including Flaviviridae, Paramyxoviridae, Rhabdoviridae, Orthomyxoviridae,"/>
 <result pre="is used for normalization of transfection efficacy. 3.3.2 Methyltransferases The" exact="viral" post="gRNAs of some RNA viruses are modified at the"/>
 <result pre="the 5′ ends with cap structures, which may be either" exact="acquired" post="from the host cell mRNA (e.g. in influenza virus)"/>
 <result pre="influenza virus) or newly synthesized (e.g. flaviviruses). The methylation of" exact="viral" post="gRNA mimics that of cellular mRNA cap structures to"/>
 <result pre="mechanisms and also to increase the efficiency of translation of" exact="viral" post="proteins. Virus-specific methyltransferases are thus a promising therapeutic target."/>
 <result pre="dengue virus (Dong et al., 2012); rhabdoviruses such as vesicular" exact="stomatitis" post="virus (VSV) (Rahmeh et al., 2009); coronaviruses such as"/>
 <result pre="3′-5′ exoribonuclease activity of the N-terminus enhances the fidelity of" exact="viral" post="replication (Case et al., 2016, Minskaia et al., 2006)."/>
 <result pre="al., 2005, Ma et al., 2014). Some cellular methyltransferases regulate" exact="viral" post="infections, as shown for herpes simplex virus, for which"/>
 <result pre="2014). Some cellular methyltransferases regulate viral infections, as shown for" exact="herpes" post="simplex virus, for which epigenetic control is involved in"/>
 <result pre="herpes simplex virus, for which epigenetic control is involved in" exact="viral" post="latency (Cliffe and Wilson, 2017). Inhibition of human histone"/>
 <result pre="been demonstrated for human cytomegalovirus (Gan et al., 2017) and" exact="herpes" post="simplex virus (Hill et al., 2014, Liang et al.,"/>
 <result pre="this method, Sun et al. constructed recombinant yeasts producing the" exact="viral" post="methyltransferase instead of the yeast one (Sun et al.,"/>
 <result pre="from flaviviruses such as dengue virus, HCV, West Nile virus," exact="yellow fever" post="virus, and Japanese encephalitis virus (Cao et al., 2016,"/>
 <result pre="dengue virus, HCV, West Nile virus, yellow fever virus, and" exact="Japanese encephalitis" post="virus (Cao et al., 2016, Gu and Rice, 2016,"/>
 <result pre="virus, HCV, West Nile virus, yellow fever virus, and Japanese" exact="encephalitis" post="virus (Cao et al., 2016, Gu and Rice, 2016,"/>
 <result pre="common in some DNA viruses, including poxviruses. These include the" exact="vaccinia" post="virus helicase-primase D5 (Bayliss and Smith, 1996, Hutin et"/>
 <result pre="Smith, 1996, Hutin et al., 2016), E1 protein of bovine" exact="papilloma" post="virus 1 (Yang et al., 1993), and the large"/>
 <result pre="papilloma virus 1 (Yang et al., 1993), and the large" exact="tumor" post="antigen of SV40 (Stahl et al., 1986). Helicases appear"/>
 <result pre="Vasudevan, 2014). Other approaches involve graphene oxide-based fluorescence monitoring of" exact="viral" post="helicase activity [reviewed in (Jang et al., 2013)]. A"/>
 <result pre="contrast to tyrosine kinases from oncogenic viruses, such as Rous" exact="sarcoma" post="virus src tyrosine kinase, viral S/T kinases share little"/>
 <result pre="oncogenic viruses, such as Rous sarcoma virus src tyrosine kinase," exact="viral" post="S/T kinases share little homology with cellular enzymes. They"/>
 <result pre="viruses (e.g. herpesviruses), in which they play important roles in" exact="viral" post="virulence, helping the virus to escape defense mechanisms such"/>
 <result pre="those of cellular cyclin-dependent kinases such as cdc2. For example," exact="viral" post="kinases can phosphorylate translation elongation factor 1 delta (EF-1δ)"/>
 <result pre="the active nucleoside triphosphate forms of the drugs that inhibit" exact="viral" post="DNA synthesis (De Clercq and Li, 2016, Kokoris and"/>
 <result pre="and Black, 2002). Some cellular protein kinases appear to support" exact="viral" post="replication. For example, polo-like kinases induce early stages in"/>
 <result pre="they are not applicable to screening inhibitors of a single" exact="viral" post="kinase. For these purposes, in vitro assays with recombinant"/>
 <result pre="in the presence of inhibitors can be quantified as ATP" exact="consumption" post="or ADP production in the phosphorylation reaction by numerous"/>
 <result pre="labeled DNA oligonucleotides comprising the terminal cis-acting sequences of linear" exact="viral" post="DNA required for integration. The joining of the processed"/>
 <result pre="method to screen molecules that inhibit binding of integrase to" exact="viral" post="DNA (Han et al., 2013). Methods evaluating the integrase"/>
 <result pre="al., 2005). 3.4 Assay and methods for screening and evaluating" exact="viral" post="assembly inhibitors The HBV capsid protein is the building"/>
 <result pre="The HBV capsid protein is the building block of the" exact="viral" post="core, surrounding the viral nucleic acid (pre-genomic RNA, pgRNA)"/>
 <result pre="is the building block of the viral core, surrounding the" exact="viral" post="nucleic acid (pre-genomic RNA, pgRNA) and reverse transcriptase. The"/>
 <result pre="2000, Rumlova-Klikova et al., 1999, Ulbrich et al., 2006), Rous" exact="sarcoma" post="virus (Campbell and Vogt, 1995, Campbell and Vogt, 1997,"/>
 <result pre="Purdy et al., 2008, Purdy et al., 2009), and murine" exact="leukemia" post="virus (Dolezal et al., 2016, Hadravova et al., 2012,"/>
 <result pre="et al., exploits the affinity of nucleocapsid (NC) to a" exact="short" post="TG-rich deoxyribooligonucleotide, d(TG25), which is used as a scaffold"/>
 <result pre="al., 2012). This arrangement enables CA to assemble at much" exact="lower" post="protein and salt concentrations than in the turbidimetric assay"/>
 <result pre="two sequential screens was developed (Breuer et al., 2012). The" exact="primary" post="screen uses fluorescence polarization (FP), while the secondary one"/>
 <result pre="2012). The primary screen uses fluorescence polarization (FP), while the" exact="secondary" post="one uses differential scanning fluorimetry (DSF). The combination and"/>
 <result pre="and then identify the compounds binding to NC during the" exact="secondary" post="screen. A rapid and simple turbidimetric method was developed"/>
 <result pre="350 nm. 3.5 Assay and methods for screening and evaluating" exact="viral" post="maturation inhibitors Numerous viruses, including picornaviruses, retroviruses, alphaviruses, and"/>
 <result pre="proteases that are essential for their virulence. The majority of" exact="viral" post="proteases specifically cleave viral polyprotein precursors to liberate the"/>
 <result pre="for their virulence. The majority of viral proteases specifically cleave" exact="viral" post="polyprotein precursors to liberate the functional proteins of the"/>
 <result pre="precursors to liberate the functional proteins of the virion. Some" exact="viral" post="proteases, such as the papain-like proteases of coronaviruses, also"/>
 <result pre="ubiquitination mechanisms and interferon controlled responses, to prevent degradation of" exact="viral" post="components (Clementz et al., 2010, Frieman et al., 2009,"/>
 <result pre="to modulate their infectivity, as shown for viruses entering airway" exact="epithelial" post="cells [reviewed in (Laporte and Naesens, 2017)] such as"/>
 <result pre="influenza virus (Böttcher-Friebertshäuser et al., 2010, Kühn et al., 2016)," exact="Newcastle disease" post="virus (Gotoh et al., 1992), and respiratory syncytial virus"/>
 <result pre="virus (Böttcher-Friebertshäuser et al., 2010, Kühn et al., 2016), Newcastle" exact="disease" post="virus (Gotoh et al., 1992), and respiratory syncytial virus"/>
 <result pre="al., 2016), Newcastle disease virus (Gotoh et al., 1992), and" exact="respiratory" post="syncytial virus (Sugrue et al., 2001). Extensive research efforts"/>
 <result pre="here were not originally designed to screen the activity of" exact="viral" post="proteases in the presence of inhibitors, they can be"/>
 <result pre="transfected with a protease precursor fused to GFP. In the" exact="absence of" post="inhibitor, HIV-1 protease is autocatalytically activated and cleaves a"/>
 <result pre="their genomes, which can result in emergence of drug-resistant mutants." exact="Viral" post="integration into the host genome and inhibitor toxicity are"/>
 <result pre="screening of antivirotics that interfere with the key steps of" exact="viral" post="life cycles and target either virus or cell-encoded proteins"/>
 <result pre="for the infectivity. References References AdedejiA.O.LazarusH.Biochemical characterization of Middle East" exact="respiratory" post="syndrome coronavirus helicasemSphere152016 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute respiratory syndrome coronavirus replication"/>
 <result pre="the infectivity. References References AdedejiA.O.LazarusH.Biochemical characterization of Middle East respiratory" exact="syndrome" post="coronavirus helicasemSphere152016 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute respiratory syndrome coronavirus replication inhibitor"/>
 <result pre="AdedejiA.O.LazarusH.Biochemical characterization of Middle East respiratory syndrome coronavirus helicasemSphere152016 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe" exact="acute" post="respiratory syndrome coronavirus replication inhibitor that interferes with the"/>
 <result pre="characterization of Middle East respiratory syndrome coronavirus helicasemSphere152016 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute" exact="respiratory" post="syndrome coronavirus replication inhibitor that interferes with the nucleic"/>
 <result pre="of Middle East respiratory syndrome coronavirus helicasemSphere152016 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute respiratory" exact="syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
 <result pre="inhibitor that interferes with the nucleic acid unwinding of the" exact="viral" post="helicaseAntimicrob. Agents Chemother.56920124718472822733076 AhiY.S.MittalS.K.Components of adenovirus genome packagingFront. Microbiol.72016150327721809"/>
 <result pre="resistance against strand transfer integrase inhibitorsRetrovirology14120173628583191 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuératG.JungM.-L.CanardB.GuillemotJ.-C.DecrolyE.Toward the identification of" exact="viral" post="cap-methyltransferase inhibitors by fluorescence screening assayAntivir. Res.144201733033928676301 ArbuckleJ.H.GardinaP.J.GordonD.N.HickmanH.D.YewdellJ.W.PiersonT.C.MyersT.G.KristieT.M.Inhibitors of"/>
 <result pre="histone methyltransferases EZH2/1 induce a potent antiviral state and suppress" exact="infection" post="by diverse viral pathogensMBio842017 AvilaC.HaddenM.K.MaZ.KornilayevB.A.YeQ.-Z.BlaggB.S.J.High-throughput screening for Hsp90 ATPase"/>
 <result pre="induce a potent antiviral state and suppress infection by diverse" exact="viral" post="pathogensMBio842017 AvilaC.HaddenM.K.MaZ.KornilayevB.A.YeQ.-Z.BlaggB.S.J.High-throughput screening for Hsp90 ATPase inhibitorsBioorg. Med. Chem."/>
 <result pre="inhibitorsBioorg. Med. Chem. Lett.161120063005300816530412 BaldickC.J.WichroskiM.J.PendriA.WalshA.W.FangJ.MazzuccoC.E.PokornowskiK.A.RoseR.E.EggersB.J.HsuM.ZhaiW.ZhaiG.GerritzS.W.PossM.A.MeanwellN.A.CockettM.I.TenneyD.J.A novel small molecule inhibitor of" exact="hepatitis" post="C virus entryPLoS Pathog.692010e100108620838466 BartonE.S.ForrestJ.C.ConnollyJ.L.ChappellJ.D.LiuY.SchnellF.J.NusratA.ParkosC.A.DermodyT.S.Junction adhesion molecule is a"/>
 <result pre="Pathog.692010e100108620838466 BartonE.S.ForrestJ.C.ConnollyJ.L.ChappellJ.D.LiuY.SchnellF.J.NusratA.ParkosC.A.DermodyT.S.Junction adhesion molecule is a receptor for reovirusCell1043200144145111239401 BartoschB.DubuissonJ.CossetF.L.Infectious" exact="hepatitis" post="C virus pseudo-particles containing functional E1-E2 envelope protein complexesJ."/>
 <result pre="I8R has both DNA and RNA helicase activities: implications for" exact="vaccinia" post="virus transcriptionJ. Virol.70219967948008551617 BeadleJ.R.ValiaevaN.YangG.YuJ.-H.BrokerT.R.AldernK.A.HardenE.A.KeithK.A.PrichardM.N.HartmanT.BuckheitR.W.ChowL.T.HostetlerK.Y.Synthesis and antiviral evaluation of octadecyloxyethyl"/>
 <result pre="evaluation of octadecyloxyethyl benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a potent inhibitor of" exact="transient" post="HPV DNA amplificationJ. Med. Chem.59232016104701047827933957 BeckJ.NassalM.Hepatitis B virus replicationWorld"/>
 <result pre="virus from intact cellsVirology479201544444925890822 BirdS.W.KirkegaardK.Nonlytic spread of naked virusesAutophagy112201543043125680079 BirdS.W.MaynardN.D.CovertM.W.KirkegaardK.Nonlytic" exact="viral" post="spread enhanced by autophagy componentsProc. Natl. Acad. Sci.111362014130811308625157142 BlaasD.Viral"/>
 <result pre="virusesWiener Medizinische Wochenschrift (1946)166201621122627174165 BoehmerP.NimonkarA.Herpes virus replicationIUBMB Life5512003132212716057 BogomolovP.AlexandrovA.VoronkovaN.MacievichM.KokinaK.PetrachenkovaM.LehrT.LemppF.A.WedemeyerH.HaagM.SchwabM.HaefeliW.E.BlankA.UrbanS.Treatment of" exact="chronic hepatitis" post="D with the entry inhibitor myrcludex B: First results"/>
 <result pre="Medizinische Wochenschrift (1946)166201621122627174165 BoehmerP.NimonkarA.Herpes virus replicationIUBMB Life5512003132212716057 BogomolovP.AlexandrovA.VoronkovaN.MacievichM.KokinaK.PetrachenkovaM.LehrT.LemppF.A.WedemeyerH.HaagM.SchwabM.HaefeliW.E.BlankA.UrbanS.Treatment of chronic" exact="hepatitis" post="D with the entry inhibitor myrcludex B: First results"/>
 <result pre="and in vivo assembly of Mason-Pfizer monkey virus and human" exact="immunodeficiency" post="virusJ. Virol.84420101977198820007269 Böttcher-FriebertshäuserE.FreuerC.SielaffF.SchmidtS.EickmannM.UhlendorffJ.SteinmetzerT.KlenkH.-D.GartenW.Cleavage of influenza virus hemagglutinin by airway"/>
 <result pre="airway proteases TMPRSS2 and HAT differs in subcellular localization and" exact="susceptibility to" post="protease inhibitorsJ. Virol.841120105605561420237084 BradleyJ.GillJ.BertelliF.LetafatS.CorbauR.HayterP.HarrisonP.TeeA.KeighleyW.PerrosM.CiaramellaG.SewingA.WilliamsC.Development and automation of a 384-well"/>
 <result pre="HIV-1 infectionNat. Rev. Microbiol.138201547148326179359 CampbellS.ReinA.In vitro assembly properties of human" exact="immunodeficiency" post="virus type 1 Gag protein lacking the p6 domainJ."/>
 <result pre="Rev. Microbiol.138201547148326179359 CampbellS.ReinA.In vitro assembly properties of human immunodeficiency virus" exact="type 1" post="Gag protein lacking the p6 domainJ. Virol.7331999227022799971810 CampbellS.VogtV.M.Self-assembly in-vitro"/>
 <result pre="type-1J. Virol.69101995648764977666550 CampbellS.VogtV.M.In vitro assembly of virus-like particles with Rous" exact="sarcoma" post="virus Gag deletion mutants: identification of the p10 domain"/>
 <result pre="and insights into Zika virus inhibitor designNucleic Acids Res.44212016105051051427915293 CarloniG.CremaA.ValliM.B.PonzettoA.ClementiM.HCV" exact="infection" post="by cell-to-cell transmission: choice or necessity?Curr. Mol. Med.1212012839522082483 CaseJ.B.AshbrookA.W.DermodyT.S.DenisonM.R.Mutagenesis"/>
 <result pre="sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in" exact="primary" post="T lymphocytesNat. Biotechnol.201120021151115412355096 CavroisM.NeidlemanJ.BigosM.GreeneW.C.Fluorescence resonance energy transfer-based HIV-1 virion"/>
 <result pre="a novel anti-HIV-1 drug targetCurr. Med. Chem.178201075075820088757 ChengS.BrooksC.L.Protein-protein interfaces in" exact="viral" post="capsids are structurally uniqueJ. Mol. Biol.4272220153613362426375252 ChengH.SchaferA.SolovevaV.GharaibehD.KennyT.RettererC.ZamaniR.BavariS.PeetN.P.RongL.Identification of a"/>
 <result pre="anti-filoviral entry inhibitorAntivir. Res.1452017243228645623 CheslockS.R.PoonD.T.FuW.RhodesT.D.HendersonL.E.NagashimaK.McGrathC.F.HuW.S.Charged assembly helix motif in murine" exact="leukemia" post="virus capsid: an important region for virus assembly and"/>
 <result pre="Microbiol. Biotechnol.251220152007201026387819 ClarkeJ.N.DaviesL.K.CalvertJ.K.GliddonB.L.Al ShujariW.H.AloiaA.L.HelbigK.J.BeardM.R.PitsonS.M.CarrJ.M.Reduction in sphingosine kinase 1 influences the" exact="susceptibility to" post="dengue virus infection by altering antiviral responsesJ. General Virol.971201695109"/>
 <result pre="ShujariW.H.AloiaA.L.HelbigK.J.BeardM.R.PitsonS.M.CarrJ.M.Reduction in sphingosine kinase 1 influences the susceptibility to dengue" exact="virus infection" post="by altering antiviral responsesJ. General Virol.971201695109 ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.LiK.MesecarA.D.BakerS.C.Deubiquitinating and interferon"/>
 <result pre="in sphingosine kinase 1 influences the susceptibility to dengue virus" exact="infection" post="by altering antiviral responsesJ. General Virol.971201695109 ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.LiK.MesecarA.D.BakerS.C.Deubiquitinating and interferon"/>
 <result pre="the susceptibility to dengue virus infection by altering antiviral responsesJ." exact="General" post="Virol.971201695109 ClementzM.A.ChenZ.BanachB.S.WangY.SunL.RatiaK.Baez-SantosY.M.WangJ.TakayamaJ.GhoshA.K.LiK.MesecarA.D.BakerS.C.Deubiquitinating and interferon antagonism activities of coronavirus papain-like"/>
 <result pre="Emerging Drugs133200839341618764719 CliffeA.R.WilsonA.C.Restarting lytic gene transcription at the onset of" exact="herpes" post="simplex virus reactivationJ. Virol.9122017e0141901416 CoatesJ.A.CammackN.JenkinsonH.J.JowettA.J.JowettM.I.PearsonB.A.PennC.R.RouseP.L.VinerK.C.CameronJ.M.(-)-2'-deoxy-3'-thiacytidine is a potent, highly"/>
 <result pre="Virol.9122017e0141901416 CoatesJ.A.CammackN.JenkinsonH.J.JowettA.J.JowettM.I.PearsonB.A.PennC.R.RouseP.L.VinerK.C.CameronJ.M.(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human" exact="immunodeficiency" post="virus type 1 and type 2 replication in vitroAntimicrob."/>
 <result pre="is a potent, highly selective inhibitor of human immunodeficiency virus" exact="type 1" post="and type 2 replication in vitroAntimicrob. Agents Chemother.36419927337391380229 CohenS.PanteN.Pushing"/>
 <result pre="highly selective inhibitor of human immunodeficiency virus type 1 and" exact="type 2" post="replication in vitroAntimicrob. Agents Chemother.36419927337391380229 CohenS.PanteN.Pushing the envelope: microinjection"/>
 <result pre="mice into Xenopus oocytes causes damage to the nuclear envelopeJ." exact="General" post="Virol.86Pt 12200532433252 CohenS.AuS.PantéN.How viruses access the nucleusBiochimica et Biophysica"/>
 <result pre="Cell Research1813920111634164521167871 ColemanC.M.SiskJ.M.MingoR.M.NelsonE.A.WhiteJ.M.FriemanM.B.Abelson kinase inhibitors are potent inhibitors of severe" exact="acute" post="respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus"/>
 <result pre="Research1813920111634164521167871 ColemanC.M.SiskJ.M.MingoR.M.NelsonE.A.WhiteJ.M.FriemanM.B.Abelson kinase inhibitors are potent inhibitors of severe acute" exact="respiratory" post="syndrome coronavirus and middle east respiratory syndrome coronavirus fusionJ."/>
 <result pre="ColemanC.M.SiskJ.M.MingoR.M.NelsonE.A.WhiteJ.M.FriemanM.B.Abelson kinase inhibitors are potent inhibitors of severe acute respiratory" exact="syndrome" post="coronavirus and middle east respiratory syndrome coronavirus fusionJ. Virol.901920168924893327466418"/>
 <result pre="inhibitors of severe acute respiratory syndrome coronavirus and middle east" exact="respiratory" post="syndrome coronavirus fusionJ. Virol.901920168924893327466418 ColomaJ.JainR.RajashankarK.R.García-SastreA.AggarwalA.K.Structures of NS5 methyltransferase from"/>
 <result pre="of severe acute respiratory syndrome coronavirus and middle east respiratory" exact="syndrome" post="coronavirus fusionJ. Virol.901920168924893327466418 ColomaJ.JainR.RajashankarK.R.García-SastreA.AggarwalA.K.Structures of NS5 methyltransferase from Zika"/>
 <result pre="NS5 methyltransferase from Zika virusCell Rep.161220163097310227633330 ColpittsC.C.El-SaghireH.PochetN.SchusterC.BaumertT.F.High-throughput approaches to unravel" exact="hepatitis" post="C virus-host interactionsVirus Res.2182016182426410623 CondezoG.N.San MartínC.Localization of adenovirus morphogenesis"/>
 <result pre="assay reveals the presence of at least two species of" exact="viral" post="capsids during synchronized HIV-1 infectionPLoS Pathog.1292016e100589727690375 DasmahapatraB.DiDomenicoB.DwyerS.MaJ.SadowskiI.SchwartzJ.A genetic system"/>
 <result pre="of linker connecting capsid and nucleocapsid protein domains in murine" exact="leukemia" post="virusJ. Biol. Chem.291392016206302064227514744 DongH.ChangD.C.HuaM.H.C.LimS.P.ChionhY.H.HiaF.LeeY.H.KukkaroP.LokS.-M.DedonP.C.ShiP.-Y.2′-O methylation of internal adenosine by"/>
 <result pre="of ebola virus replicationACS Infect. Dis.18201538038726284260 EhrlichL.S.AgrestaB.E.CarterC.A.Assembly of recombinant human" exact="immunodeficiency" post="virus type 1 capsid protein in vitroJ. Virol.6681992487448831629958 ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification"/>
 <result pre="virus replicationACS Infect. Dis.18201538038726284260 EhrlichL.S.AgrestaB.E.CarterC.A.Assembly of recombinant human immunodeficiency virus" exact="type 1" post="capsid protein in vitroJ. Virol.6681992487448831629958 ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification of a broad-spectrum"/>
 <result pre="Virol.6681992487448831629958 ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification of a broad-spectrum antiviral small molecule against severe" exact="acute" post="respiratory syndrome coronavirus and ebola, hendra, and nipah viruses"/>
 <result pre="ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification of a broad-spectrum antiviral small molecule against severe acute" exact="respiratory" post="syndrome coronavirus and ebola, hendra, and nipah viruses by"/>
 <result pre="of a broad-spectrum antiviral small molecule against severe acute respiratory" exact="syndrome" post="coronavirus and ebola, hendra, and nipah viruses by using"/>
 <result pre="for clinical kinase inhibitorsNat. Biotechnol.233200532933615711537 FalconV.Acosta-RiveroN.GonzalezS.Duenas-CarreraS.Martinez-DonatoG.MenendezI.GarateixR.SilvaJ.A.AcostaE.KouriJ.Ultrastructural and biochemical basis for" exact="hepatitis" post="C virus morphogenesisVirus Genes532201715116428233195 FayN.PantéN.Nuclear entry of DNA virusesFront."/>
 <result pre="picornavirus acquires an envelope by hijacking cellular membranesNature4967445201336737123542590 FengJ.Y.ChengG.PerryJ.BarauskasO.XuY.FenauxM.EngS.TirunagariN.PengB.YuM.TianY.LeeY.-J.StepanG.LagpacanL.L.JinD.HungM.KuK.S.HanB.KitrinosK.PerronM.BirkusG.WongK.A.ZhongW.KimC.U.CareyA.ChoA.RayA.S.Inhibition of" exact="hepatitis" post="C virus replication by GS-6620, a potent C-nucleoside monophosphate"/>
 <result pre="&amp;amp; WilkinsPhiladelphia FooteB.S.SpoonerL.M.BelliveauP.P.Boceprevir: a protease inhibitor for the treatment of" exact="chronic" post="Hepatitis CAnn. Pharmacother.45920111085109321828346 FreedE.O.Viral late domainsJ. Virol.761020024679468711967285 FreedE.O.HIV-1 assembly,"/>
 <result pre="WilkinsPhiladelphia FooteB.S.SpoonerL.M.BelliveauP.P.Boceprevir: a protease inhibitor for the treatment of chronic" exact="Hepatitis" post="CAnn. Pharmacother.45920111085109321828346 FreedE.O.Viral late domainsJ. Virol.761020024679468711967285 FreedE.O.HIV-1 assembly, release"/>
 <result pre="Microbiol.138201548449626119571 FrickD.N.Helicases as antiviral drug targetsDrug News &amp;amp; Perspectives166200335536212973446 FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe" exact="acute" post="respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic"/>
 <result pre="FrickD.N.Helicases as antiviral drug targetsDrug News &amp;amp; Perspectives166200335536212973446 FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe acute" exact="respiratory" post="syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain"/>
 <result pre="as antiviral drug targetsDrug News &amp;amp; Perspectives166200335536212973446 FriemanM.RatiaK.JohnstonR.E.MesecarA.D.BaricR.S.Severe acute respiratory" exact="syndrome" post="coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate"/>
 <result pre="signalingJ. Virol.831320096689670519369340 FromentinR.MajeauN.Laliberte GagneM.E.BoivinA.DuvignaudJ.B.LeclercD.A method for in vitro assembly of" exact="hepatitis" post="C virus core protein and for screening of inhibitorsAnal."/>
 <result pre="bovine adenovirus 3-encoded pVIIIJ. Virol.91102017 GanX.WangH.YuY.YiW.ZhuS.LiE.LiangY.Epigenetically repressing human cytomegalovirus lytic" exact="infection" post="and reactivation from latency in THP-1 model by targeting"/>
 <result pre="and H3K27 histone demethylasesPLoS One1242017e017539028407004 GastaminzaP.Whitten-BauerC.ChisariF.V.Unbiased probing of the entire" exact="hepatitis" post="C virus life cycle identifies clinical compounds that target"/>
 <result pre="formation of the cytomegalovirus virionCurr. Top. Microbiol. Immunol.325200818720418637507 GlebeD.AliakbariM.KrassP.KnoopE.V.ValeriusK.P.GerlichW.H.Pre-s1 antigen-dependent" exact="infection" post="of Tupaia hepatocyte cultures with human hepatitis B virusJ."/>
 <result pre="Immunol.325200818720418637507 GlebeD.AliakbariM.KrassP.KnoopE.V.ValeriusK.P.GerlichW.H.Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human" exact="hepatitis" post="B virusJ. Virol.771720039511952112915565 GlebeD.UrbanS.KnoopE.V.ÇaǧN.KrassP.GrünS.BulavaiteA.SasnauskasK.GerlichW.H.Mapping of the Hepatitis B Virus"/>
 <result pre="cultures with human hepatitis B virusJ. Virol.771720039511952112915565 GlebeD.UrbanS.KnoopE.V.ÇaǧN.KrassP.GrünS.BulavaiteA.SasnauskasK.GerlichW.H.Mapping of the" exact="Hepatitis" post="B Virus attachment site by use of infection-inhibiting preS1"/>
 <result pre="proteolytic enzymes using rhodamine-based fluorogenic substratesJ. Biomol. Screen.76200253154014599351 GriponP.DiotC.ThezeN.FourelI.LorealO.BrechotC.Guguen-GuillouzoC.Hepatitis B" exact="virus infection" post="of adult human hepatocytes cultured in the presence of"/>
 <result pre="enzymes using rhodamine-based fluorogenic substratesJ. Biomol. Screen.76200253154014599351 GriponP.DiotC.ThezeN.FourelI.LorealO.BrechotC.Guguen-GuillouzoC.Hepatitis B virus" exact="infection" post="of adult human hepatocytes cultured in the presence of"/>
 <result pre="rhodamine-based fluorogenic substratesJ. Biomol. Screen.76200253154014599351 GriponP.DiotC.ThezeN.FourelI.LorealO.BrechotC.Guguen-GuillouzoC.Hepatitis B virus infection of" exact="adult" post="human hepatocytes cultured in the presence of dimethyl sulfoxideJ."/>
 <result pre="Virol.62111988413641433172341 GriponP.RuminS.UrbanS.Le SeyecJ.GlaiseD.CannieI.GuyomardC.LucasJ.TrepoC.Guguen-GuillouzoC.Infection of a human hepatoma cell line by" exact="hepatitis" post="B virusProc. Natl. Acad. Sci.99242002156551566012432097 GriponP.CannieI.UrbanS.Efficient inhibition of Hepatitis"/>
 <result pre="by hepatitis B virusProc. Natl. Acad. Sci.99242002156551566012432097 GriponP.CannieI.UrbanS.Efficient inhibition of" exact="Hepatitis" post="B Virus infection by acylated peptides derived from the"/>
 <result pre="virusProc. Natl. Acad. Sci.99242002156551566012432097 GriponP.CannieI.UrbanS.Efficient inhibition of Hepatitis B Virus" exact="infection" post="by acylated peptides derived from the large viral surface"/>
 <result pre="B Virus infection by acylated peptides derived from the large" exact="viral" post="surface proteinJ. Virol.79320051613162215650187 GrønborgM.KristiansenT.Z.StensballeA.AndersenJ.S.OharaO.MannM.JensenO.N.PandeyA.A mass spectrometry-based proteomic approach for"/>
 <result pre="as a protein kinase A substrateMol. Cell. Proteomics17200251752712239280 GroseC.BuckinghamE.M.CarpenterJ.E.KunkelJ.P.Varicella-zoster virus" exact="infectious" post="cycle: ER stress, autophagic flux, and amphisome-mediated traffickingPathogens (Basel,"/>
 <result pre="vitro assembly of virus-like particles of a gammaretrovirus, the murine" exact="leukemia" post="virus XMRVJ. Virol.86320121297130622090120 HadravovaR.RumlovaM.RumlT.FAITH - fast assembly inhibitor test"/>
 <result pre="Virus EgressJ. Infect. Dis.212Suppl. 22015S13814525786915 HaoW.WojdylaJ.A.ZhaoR.HanR.DasR.ZlatevI.ManoharanM.WangM.CuiS.Crystal structure of Middle East" exact="respiratory" post="syndrome coronavirus helicasePLoS Pathog.1362017e100647428651017 HeH.Q.MaX.H.LiuB.ZhangX.Y.ChenW.Z.WangC.X.ChengS.H.High-throughput real-time assay based on"/>
 <result pre="EgressJ. Infect. Dis.212Suppl. 22015S13814525786915 HaoW.WojdylaJ.A.ZhaoR.HanR.DasR.ZlatevI.ManoharanM.WangM.CuiS.Crystal structure of Middle East respiratory" exact="syndrome" post="coronavirus helicasePLoS Pathog.1362017e100647428651017 HeH.Q.MaX.H.LiuB.ZhangX.Y.ChenW.Z.WangC.X.ChengS.H.High-throughput real-time assay based on molecular"/>
 <result pre="herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of" exact="viral" post="genomes. Sci. Transl. Med. 6(265), 265ra169-265ra169. HiltonB.J.WolkowiczR.An assay to"/>
 <result pre="inhibitors in T-cellsPLoS One562010e1094020532177 HirashimaS.SuzukiT.IshidaT.NojiS.YataS.AndoI.KomatsuM.IkedaS.HashimotoH.Benzimidazole derivatives bearing substituted biphenyls as" exact="Hepatitis" post="C Virus NS5B RNA-Dependent RNA polymerase inhibitors: structure −"/>
 <result pre="enzymatic RNA synthesisJ. Am. Chem. Soc.135372013136921369423991672 HoldenM.J.HaynesR.J.RabbS.A.SatijaN.YangK.BlasicJ.R.Factors affecting quantification of" exact="total" post="DNA by UV spectroscopy and picogreen fluorescenceJ. Agric. Food"/>
 <result pre="outs of eukaryotic viruses: Knowledge base and ontology of a" exact="viral" post="infectionPLoS One1222017e017174628207819 HurleyJ.H.ESCRTs are everywhereEMBO J.341920152398240726311197 HutchinsonE.C.FodorE.Transport of the"/>
 <result pre="influenza virus genome from nucleus to nucleusViruses51020132424244624104053 HutinS.LingW.L.RoundA.EffantinG.ReichS.IseniF.TarbouriechN.SchoehnG.BurmeisterW.P.Domain organization of" exact="vaccinia" post="virus Helicase-Primase D5J. Virol.90920164604461326912611 InoueT.TsaiB.How viruses use the endoplasmic"/>
 <result pre="oxide for anti-viral drug developmentMol. Cell3542013269273 JasenoskyL.D.KawaokaY.Filovirus buddingVirus Res.1062200418118815567496 JayaramanB.SmithA.M.FernandesJ.D.FrankelA.D.Oligomeric" exact="viral" post="proteins: small in size, large in presenceCrit. Rev. Biochem."/>
 <result pre="mechanism by which Us3 protein kinase regulates the pathogenicity of" exact="herpes" post="simplex virus type-1Uirusu6612016839028484184 KatoT.DateT.MurayamaA.MorikawaK.AkazawaD.WakitaT.Cell culture and infection system for"/>
 <result pre="the pathogenicity of herpes simplex virus type-1Uirusu6612016839028484184 KatoT.DateT.MurayamaA.MorikawaK.AkazawaD.WakitaT.Cell culture and" exact="infection" post="system for hepatitis C virusNat. Protoc.1520062334233917406476 KatzR.A.MerkelG.KulkoskyJ.LeisJ.SkalkaA.M.The avian retroviral"/>
 <result pre="herpes simplex virus type-1Uirusu6612016839028484184 KatoT.DateT.MurayamaA.MorikawaK.AkazawaD.WakitaT.Cell culture and infection system for" exact="hepatitis" post="C virusNat. Protoc.1520062334233917406476 KatzR.A.MerkelG.KulkoskyJ.LeisJ.SkalkaA.M.The avian retroviral IN protein is"/>
 <result pre="avian retroviral integration protein cleaves the terminal sequences of linear" exact="viral" post="DNA at the in vivo sites of integrationJ. Virol.63121989531953272555556"/>
 <result pre="peptide based biosensorBioImpacts63201613514727853677 KilianskiA.MielechA.M.DengX.BakerS.C.Assessing activity and inhibition of middle east" exact="respiratory" post="syndrome coronavirus papain-like and 3C-Like proteases using luciferase-based biosensorsJ."/>
 <result pre="based biosensorBioImpacts63201613514727853677 KilianskiA.MielechA.M.DengX.BakerS.C.Assessing activity and inhibition of middle east respiratory" exact="syndrome" post="coronavirus papain-like and 3C-Like proteases using luciferase-based biosensorsJ. Virol.87212013119551196223986593"/>
 <result pre="KobilerO.DraymanN.Butin-IsraeliV.OppenheimA.Virus strategies for passing the nuclear envelope barrierNucleus36201252653922929056 KokorisM.S.BlackM.E.Characterization of" exact="herpes" post="simplex virus type 1 thymidine kinase mutants engineered for"/>
 <result pre="passing the nuclear envelope barrierNucleus36201252653922929056 KokorisM.S.BlackM.E.Characterization of herpes simplex virus" exact="type 1" post="thymidine kinase mutants engineered for improved ganciclovir or acyclovir"/>
 <result pre="of (H3N2) Influenza A Virus Hemagglutinin is facilitated by different" exact="type II" post="transmembrane serine proteasesJ. Virol.90920164298430726889029 KuoC.J.ChiY.H.HsuJ.T.LiangP.H.Characterization of SARS main protease"/>
 <result pre="as antiviral targetsNat. Rev. Drug Discov.410200584585316184083 LadnerS.K.OttoM.J.BarkerC.S.ZaifertK.WangG.H.GuoJ.T.SeegerC.KingR.W.Inducible expression of human" exact="hepatitis" post="B virus (HBV) in stably transfected hepatoblastoma cells: a"/>
 <result pre="expression of human hepatitis B virus (HBV) in stably transfected" exact="hepatoblastoma" post="cells: a novel system for screening potential inhibitors of"/>
 <result pre="LanmanJ.SextonJ.SakalianM.PreveligeP.E.Jr.Kinetic analysis of the role of intersubunit interactions in human" exact="immunodeficiency" post="virus type 1 capsid protein assembly in vitroJ. Virol.761420026900690812072491"/>
 <result pre="of the role of intersubunit interactions in human immunodeficiency virus" exact="type 1" post="capsid protein assembly in vitroJ. Virol.761420026900690812072491 LaporteM.NaesensL.Airway proteases: an"/>
 <result pre="LaporteM.NaesensL.Airway proteases: an emerging drug target for influenza and other" exact="respiratory" post="virus infectionsCurr. Opin. Virol.242017162428414992 LathiaU.S.OrnatskyO.BaranovV.NitzM.Multiplexed protease assays using element-tagged"/>
 <result pre="bind the same site within the N-terminal domain of the" exact="viral" post="CA proteinJ. Virol.861220126643665522496222 LeuchowiusK.-J.JarviusM.WickströmM.RickardsonL.LandegrenU.LarssonR.SöderbergO.FryknäsM.JarviusJ.High content screening for inhibitors of"/>
 <result pre="screening for inhibitors of protein interactions and post-translational modifications in" exact="primary" post="cells by proximity ligationMol. Cell. Proteomics91201017818319864249 LeungK.-H.HeH.-Z.HeB.ZhongH.-J.LinS.WangY.-T.MaD.-L.LeungC.-H.Label-free luminescence switch-on"/>
 <result pre="by proximity ligationMol. Cell. Proteomics91201017818319864249 LeungK.-H.HeH.-Z.HeB.ZhongH.-J.LinS.WangY.-T.MaD.-L.LeungC.-H.Label-free luminescence switch-on detection of" exact="hepatitis" post="C virus NS3 helicase activity using a G-quadruplex-selective probe"/>
 <result pre="additional data fileChem. Sci.6420152166217128808523 LevingsR.L.RothJ.A.Immunity to bovine herpesvirus 1: I." exact="Viral" post="lifecycle and innate immunityAnim. Health Res. Rev.14120138810223800429 LiM.YoungrenJ.F.ManchemV.P.KozlowskiM.ZhangB.B.MadduxB.A.GoldfineI.D.Small molecule"/>
 <result pre="LiJ.Fontaine-RodriguezE.C.WhelanS.P.J.Amino acid residues within conserved domain VI of the vesicular" exact="stomatitis" post="virus large polymerase protein essential for mRNA cap methyltransferase"/>
 <result pre="polymerase protein essential for mRNA cap methyltransferase activityJ. Virol.79212005133731338416227259 LiJ.ChorbaJ.S.WhelanS.P.Vesicular" exact="stomatitis" post="viruses resistant to the methylase inhibitor sinefungin upregulate RNA"/>
 <result pre="from latencyNat. Med.151120091312131719855399 LiangY.QuenelleD.VogelJ.L.MascaroC.OrtegaA.KristieT.M.A novel selective LSD1/KDM1A inhibitor epigenetically blocks" exact="herpes" post="simplex virus lytic replication and reactivation from latencyMBio412013e00512e00558 Liao,"/>
 <result pre="LinC.T.TritschlerF.LeeK.S.GuM.RiceC.M.HaT.Single-molecule imaging reveals the translocation and DNA looping dynamics of" exact="hepatitis" post="C virus NS3 helicaseProtein Sci.26720171391140328176403 Lindsten, K., Uhlíková, T.á.,"/>
 <result pre="Masucci, M.G., Dantuma, N.P., 2001. Cell-based fluorescence assay for human" exact="immunodeficiency" post="virus Type 1 protease activity. Antimicrob. Agents Chemother. 45(9),"/>
 <result pre="Dantuma, N.P., 2001. Cell-based fluorescence assay for human immunodeficiency virus" exact="Type 1" post="protease activity. Antimicrob. Agents Chemother. 45(9), 2616-2622. LiuY.HartyR.N.Viral and"/>
 <result pre="HIV-1 fusion inhibitorsJ. Virol. Methods1072200315516112505629 LuL.LiuQ.ZhuY.ChanK.-H.QinL.LiY.WangQ.ChanJ.F.-W.DuL.YuF.MaC.YeS.YuenK.-Y.ZhangR.JiangS.Structure-based discovery of Middle East" exact="respiratory" post="syndrome coronavirus fusion inhibitorNat. Commun.530672014 LukicZ.DharanA.FrickeT.Diaz-GrifferoF.CampbellE.M.HIV-1 uncoating is facilitated"/>
 <result pre="fusion inhibitorsJ. Virol. Methods1072200315516112505629 LuL.LiuQ.ZhuY.ChanK.-H.QinL.LiY.WangQ.ChanJ.F.-W.DuL.YuF.MaC.YeS.YuenK.-Y.ZhangR.JiangS.Structure-based discovery of Middle East respiratory" exact="syndrome" post="coronavirus fusion inhibitorNat. Commun.530672014 LukicZ.DharanA.FrickeT.Diaz-GrifferoF.CampbellE.M.HIV-1 uncoating is facilitated by"/>
 <result pre="Soc.130382008128211282718759402 LütgehetmannM.ManckeL.V.VolzT.HelbigM.AllweissL.BornscheuerT.PollokJ.M.LohseA.W.PetersenJ.UrbanS.DandriM.Humanized chimeric uPA mouse model for the study of" exact="hepatitis" post="B and D virus interactions and preclinical drug evaluationHepatology553201268569422031488"/>
 <result pre="drug evaluationHepatology553201268569422031488 LuyetP.P.FalguieresT.PonsV.PattnaikA.K.GruenbergJ.The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of" exact="viral" post="RNATraffic (Copenhagen, Denmark)912200822792290 MaH.DeaconS.HoriuchiK.The challenge of selecting protein kinase"/>
 <result pre="Opin. Drug Discovery362008607621 MaY.WeiY.ZhangX.ZhangY.CaiH.ZhuY.ShiloK.OglesbeeM.KrakowkaS.WhelanS.P.J.LiJ.mRNA cap methylation influences pathogenesis of vesicular" exact="stomatitis" post="virus in vivoJ. Virol.88520142913292624371058 MadhviA.HinganeS.SrivastavR.JoshiN.SubramaniC.MuthumohanR.KhasaR.VarshneyS.KaliaM.VratiS.SurjitM.Ranjith-KumarC.T.A screen for novel hepatitis"/>
 <result pre="vesicular stomatitis virus in vivoJ. Virol.88520142913292624371058 MadhviA.HinganeS.SrivastavR.JoshiN.SubramaniC.MuthumohanR.KhasaR.VarshneyS.KaliaM.VratiS.SurjitM.Ranjith-KumarC.T.A screen for novel" exact="hepatitis" post="C virus RdRp inhibitor identifies a broad-spectrum antiviral compoundSci."/>
 <result pre="MartínC.Structure, function and dynamics in adenovirus maturationViruses61120144536457025421887 MarchandC.NeamatiN.PommierY.In vitro human" exact="immunodeficiency" post="virus type 1 integrase assaysMethods Enzymol.340200162463311494874 MarechalV.PrevostM.C.PetitC.PerretE.HeardJ.M.SchwartzO.Human immunodeficiency virus"/>
 <result pre="and dynamics in adenovirus maturationViruses61120144536457025421887 MarchandC.NeamatiN.PommierY.In vitro human immunodeficiency virus" exact="type 1" post="integrase assaysMethods Enzymol.340200162463311494874 MarechalV.PrevostM.C.PetitC.PerretE.HeardJ.M.SchwartzO.Human immunodeficiency virus type 1 entry"/>
 <result pre="vitro human immunodeficiency virus type 1 integrase assaysMethods Enzymol.340200162463311494874 MarechalV.PrevostM.C.PetitC.PerretE.HeardJ.M.SchwartzO.Human" exact="immunodeficiency" post="virus type 1 entry into macrophages mediated by macropinocytosisJ."/>
 <result pre="immunodeficiency virus type 1 integrase assaysMethods Enzymol.340200162463311494874 MarechalV.PrevostM.C.PetitC.PerretE.HeardJ.M.SchwartzO.Human immunodeficiency virus" exact="type 1" post="entry into macrophages mediated by macropinocytosisJ. Virol.75222001111661117711602756 MatreyekK.A.EngelmanA.Viral and"/>
 <result pre="of infectionYale J. Biol. Med.9012017253328356891 MelikyanG.B.Common principles and intermediates of" exact="viral" post="protein-mediated fusion: the HIV-1 paradigmRetrovirology5200811119077194 Menéndez-AriasL.AndinoR.Viral polymerasesVirus Res.23420171328188807 MercerJ.HeleniusA.Virus"/>
 <result pre="entry by macropinocytosisNat. Cell Biol.115200951052019404330 MercerJ.HeleniusA.Apoptotic mimicry: phosphatidylserine-mediated macropinocytosis of" exact="vaccinia" post="virusAnn. N. Y. Acad. Sci.12092010495520958316 MerkelG.AndrakeM.D.RamcharanJ.SkalkaA.M.Oligonucleotide-based assays for integrase"/>
 <result pre="their use in kinetic analyses of wild-type and mutant Rous" exact="sarcoma" post="virus integrasesProc. Natl. Acad. Sci. U. S. A.9024199311633116378265600 MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.M.N.JoshiS.K.Advances"/>
 <result pre="fused HIV-1 proteinase: a simple assay for inhibitors of the" exact="viral" post="enzyme activityGene134119931231288244023 NedjadiT.El-KafrawyS.SohrabS.S.DespresP.DamanhouriG.AzharE.Tackling dengue fever: current status and challengesVirol."/>
 <result pre="of polymerase inhibitors as antiviral drugsAntivir. Res.7122006909516820225 OjalaP.M.SodeikB.EbersoldM.W.KutayU.HeleniusA.Herpes simplex virus" exact="type 1" post="Entry into host cells: reconstitution of capsid binding and"/>
 <result pre="Biol.83200718519417318224 PasdeloupD.BlondelD.IsidroA.L.RixonF.J.Herpesvirus capsid association with the nuclear pore complex and" exact="viral" post="dna release INVOLVE THE Nucleoporin CAN/Nup214 and the Capsid"/>
 <result pre="viral dna release INVOLVE THE Nucleoporin CAN/Nup214 and the Capsid" exact="Protein" post="pUL25J. Virol.831320096610662319386703 PawlotskyJ.M.ChevaliezS.McHutchisonJ.G.The Hepatitis C Virus life cycle as"/>
 <result pre="THE Nucleoporin CAN/Nup214 and the Capsid Protein pUL25J. Virol.831320096610662319386703 PawlotskyJ.M.ChevaliezS.McHutchisonJ.G.The" exact="Hepatitis" post="C Virus life cycle as a target for new"/>
 <result pre="and protease activitiesJ. Enzyme Inhibition Med. Chem.321201710911101 PetersenJ.DandriM.MierW.LutgehetmannM.VolzT.von WeizsackerF.HaberkornU.FischerL.PollokJ.M.ErbesB.SeitzS.UrbanS.Prevention of" exact="hepatitis" post="B virus infection in vivo by entry inhibitors derived"/>
 <result pre="activitiesJ. Enzyme Inhibition Med. Chem.321201710911101 PetersenJ.DandriM.MierW.LutgehetmannM.VolzT.von WeizsackerF.HaberkornU.FischerL.PollokJ.M.ErbesB.SeitzS.UrbanS.Prevention of hepatitis B" exact="virus infection" post="in vivo by entry inhibitors derived from the large"/>
 <result pre="Enzyme Inhibition Med. Chem.321201710911101 PetersenJ.DandriM.MierW.LutgehetmannM.VolzT.von WeizsackerF.HaberkornU.FischerL.PollokJ.M.ErbesB.SeitzS.UrbanS.Prevention of hepatitis B virus" exact="infection" post="in vivo by entry inhibitors derived from the large"/>
 <result pre="PietiläM.K.HellströmK.AholaT.Alphavirus polymerase and RNA replicationVirus Res.2342017445728104453 PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.-H.An overview of severe" exact="acute" post="respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small"/>
 <result pre="polymerase and RNA replicationVirus Res.2342017445728104453 PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.-H.An overview of severe acute" exact="respiratory" post="syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule"/>
 <result pre="Methods and Protocols2012Humana PressTotowa, NJ2131 PlossA.EvansM.J.GaysinskayaV.A.PanisM.YouH.de JongY.P.RiceC.M.Human occludin is a" exact="hepatitis" post="C virus entry factor required for infection of mouse"/>
 <result pre="occludin is a hepatitis C virus entry factor required for" exact="infection" post="of mouse cellsNature4577231200988288619182773 PodanyA.T.ScarsiK.K.FletcherC.V.Comparative clinical pharmacokinetics and pharmacodynamics of"/>
 <result pre="A virus replication cycle-a tight interplay between virus and hostJ." exact="General" post="Virol.979201620582072 Pohl, M.O., von Recum-Knepper, J., Rodriguez-Frandsen, A., Lanz,"/>
 <result pre="the CA dimer in initiationJ. Mol. Biol.3892200943845119361521 RabeB.VlachouA.PanteN.HeleniusA.KannM.Nuclear import of" exact="hepatitis" post="B virus capsids and release of the viral genomeProc."/>
 <result pre="import of hepatitis B virus capsids and release of the" exact="viral" post="genomeProc. Natl. Acad. Sci. U. S. A.1001720039849985412909718 RaguramA.SasisekharanV.SasisekharanR.A chiral"/>
 <result pre="virus capsid structuresTrends Microbiol.256201743844628094093 RahmehA.A.LiJ.KranzuschP.J.WhelanS.P.Ribose 2'-O methylation of the vesicular" exact="stomatitis" post="virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation"/>
 <result pre="disassemblyJ. Virol.91122017 RasmussenI.VilhardtF.Macropinocytosis is the entry mechanism of amphotropic murine" exact="leukemia" post="virusJ. Virol.89320151851186625428868 RayD.ShahA.TilgnerM.GuoY.ZhaoY.DongH.DeasT.S.ZhouY.LiH.ShiP.-Y.West Nile Virus 5′-Cap structure is formed"/>
 <result pre="protein 5J. Virol.801720068362837016912287 RazonableR.R.Antiviral drugs for viruses other than human" exact="immunodeficiency" post="virusMayo Clin. Proc.861020111009102621964179 ReyF.A.StiasnyK.HeinzF.X.Flavivirus structural heterogeneity: implications for cell"/>
 <result pre="cell entryCurrent Opinion Virol.242017132139 ReynoldsK.A.CameronC.E.RaneyK.D.Melting of duplex DNA in the" exact="absence of" post="ATP by NS3 helicase domain through specific interaction with"/>
 <result pre="helicase domain through specific interaction with a single-strand/double-strand junctionBiochemistry542720154248425826091150 RichardsA.L.JacksonW.T.Intracellular" exact="vesicle" post="acidification promotes maturation of infectious poliovirus particlesPLoS Pathog.8112012e100304623209416 RoeT.ReynoldsT.C.YuG.BrownP.O.Integration"/>
 <result pre="with a single-strand/double-strand junctionBiochemistry542720154248425826091150 RichardsA.L.JacksonW.T.Intracellular vesicle acidification promotes maturation of" exact="infectious" post="poliovirus particlesPLoS Pathog.8112012e100304623209416 RoeT.ReynoldsT.C.YuG.BrownP.O.Integration of murine leukemia virus DNA"/>
 <result pre="promotes maturation of infectious poliovirus particlesPLoS Pathog.8112012e100304623209416 RoeT.ReynoldsT.C.YuG.BrownP.O.Integration of murine" exact="leukemia" post="virus DNA depends on mitosisEMBO J.1251993209921088491198 RossignolE.D.YangJ.E.BullittE.the role of"/>
 <result pre="measurement of protein kinase activityAssay Drug Dev Technol76200961562220105027 SatoY.KoshizukaT.IshibashiK.HashimotoK.IshiokaK.IkutaK.YokotaS.I.FujiiN.SuzutaniT.Involvement of" exact="herpes" post="simplex virus type 1 UL13 protein kinase in induction"/>
 <result pre="kinase activityAssay Drug Dev Technol76200961562220105027 SatoY.KoshizukaT.IshibashiK.HashimotoK.IshiokaK.IkutaK.YokotaS.I.FujiiN.SuzutaniT.Involvement of herpes simplex virus" exact="type 1" post="UL13 protein kinase in induction of SOCS genes, the"/>
 <result pre="SchmiedelD.TaiJ.Levi-SchafferF.DovratS.MandelboimO.Human Herpesvirus 6B downregulates expression of activating ligands during lytic" exact="infection" post="to escape elimination by natural killer cellsJ. Virol.902120169608961727535049 SchwartzJ.J.QuakeS.R.Single"/>
 <result pre="ScourfieldE.J.Martin-SerranoJ.Growing functions of the ESCRT machinery in cell biology and" exact="viral" post="replicationBiochem. Soc. Trans.453201761363428620025 SellsM.A.ChenM.L.AcsG.Production of hepatitis B virus particles"/>
 <result pre="in cell biology and viral replicationBiochem. Soc. Trans.453201761363428620025 SellsM.A.ChenM.L.AcsG.Production of" exact="hepatitis" post="B virus particles in Hep G2 cells transfected with"/>
 <result pre="B virus particles in Hep G2 cells transfected with cloned" exact="hepatitis" post="B virus DNAProc. Natl. Acad. Sci. U. S. A.8441987100510093029758"/>
 <result pre="reservoir host to the human coronavirus that causes Middle East" exact="Respiratory" post="Syndrome (MERS)Bioorg. Med. Chem.231720156036604826190463 StahlH.DrögeP.KnippersR.DNA helicase activity of SV40"/>
 <result pre="host to the human coronavirus that causes Middle East Respiratory" exact="Syndrome" post="(MERS)Bioorg. Med. Chem.231720156036604826190463 StahlH.DrögeP.KnippersR.DNA helicase activity of SV40 large"/>
 <result pre="Syndrome (MERS)Bioorg. Med. Chem.231720156036604826190463 StahlH.DrögeP.KnippersR.DNA helicase activity of SV40 large" exact="tumor" post="antigenEMBO J.581986193919443019672 StaufferS.NebiogluF.HeleniusA.In vitro disassembly of influenza A virus"/>
 <result pre="StrayS.J.JohnsonJ.M.KopekB.G.ZlotnickA.An in vitro fluorescence screen to identify antivirals that disrupt" exact="hepatitis" post="B virus capsid assemblyNat. Biotechnol.243200635836216474383 StremlauM.PerronM.LeeM.LiY.SongB.JavanbakhtH.Diaz-GrifferoF.AndersonD.J.SundquistW.I.SodroskiJ.Specific recognition and accelerated"/>
 <result pre="Sci. U. S. A.1031420065514551916540544 SugrueR.J.BrownC.BrownG.AitkenJ.McL. Rixon, H.W.Furin cleavage of the" exact="respiratory" post="syncytial virus fusion protein is not a requirement for"/>
 <result pre="of inhibitors of coronavirus RNA cap guanine-N7-methyltransferaseAntivir. Res.104201415616424530452 SureauC.Romet-LemonneJ.-L.MullinsJ.I.EssexM.Production of" exact="hepatitis" post="B virus by a differentiated human hepatoma cell line"/>
 <result pre="of the HIV-1 capsid by MELK triggers uncoating to promote" exact="viral" post="cDNA synthesisPLoS Pathog.1372017e100644128683086 TandonR.MocarskiE.S.Viral and host control of cytomegalovirus"/>
 <result pre="isonucleoside analogsJ. Med. Chem.3691993122112298387600 TisdaleM.KempS.D.ParryN.R.LarderB.A.Rapid in vitro selection of human" exact="immunodeficiency" post="virus type 1 resistant to 3'-thiacytidine inhibitors due to"/>
 <result pre="Med. Chem.3691993122112298387600 TisdaleM.KempS.D.ParryN.R.LarderB.A.Rapid in vitro selection of human immunodeficiency virus" exact="type 1" post="resistant to 3'-thiacytidine inhibitors due to a mutation in"/>
 <result pre="Sci. U. S. A.90121993565356567685907 TomarS.JohnstonM.L.St. JohnS.E.OsswaldH.L.NyalapatlaP.R.PaulL.N.GhoshA.K.DenisonM.R.MesecarA.D.Ligand-induced dimerization of middle east" exact="respiratory" post="syndrome (MERS) coronavirus nsp5 Protease (3CL(pro)): implications for nsp5"/>
 <result pre="U. S. A.90121993565356567685907 TomarS.JohnstonM.L.St. JohnS.E.OsswaldH.L.NyalapatlaP.R.PaulL.N.GhoshA.K.DenisonM.R.MesecarA.D.Ligand-induced dimerization of middle east respiratory" exact="syndrome" post="(MERS) coronavirus nsp5 Protease (3CL(pro)): implications for nsp5 regulation"/>
 <result pre="assay for sensitive detection of virus entryJ. Virol. Methods1632201033634319879300 UdukalaD.N.WangH.WendelS.O.MalalasekeraA.P.SamarakoonT.N.YapaA.S.AbayaweeraG.BaselM.T.MaynezP.OrtegaR.ToledoY.BossmannL.RobinsonC.JanikK.E.KoperO.B.LiP.MotamediM.HigginsD.A.GadburyG.ZhuG.TroyerD.L.BossmannS.H.Early" exact="breast cancer" post="screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of"/>
 <result pre="for sensitive detection of virus entryJ. Virol. Methods1632201033634319879300 UdukalaD.N.WangH.WendelS.O.MalalasekeraA.P.SamarakoonT.N.YapaA.S.AbayaweeraG.BaselM.T.MaynezP.OrtegaR.ToledoY.BossmannL.RobinsonC.JanikK.E.KoperO.B.LiP.MotamediM.HigginsD.A.GadburyG.ZhuG.TroyerD.L.BossmannS.H.Early breast" exact="cancer" post="screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of"/>
 <result pre="Virol.801420067089709916809314 UtamaA.ShimizuH.MorikawaS.HasebeF.MoritaK.IgarashiA.HatsuM.TakamizawaK.MiyamuraT.Identification and characterization of the RNA helicase activity of" exact="Japanese encephalitis" post="virus NS3 proteinFEBS Lett.46512000747810620709 VeeslerD.JohnsonJ.E.Virus maturationAnnu. Rev. Biophys.41201247349622404678 VlachJ.LipovJ.RumlovaM.VeverkaV.LangJ.SrbP.KnejzlikZ.PichovaI.HunterE.HrabalR.RumlT.D-retrovirus"/>
 <result pre="UtamaA.ShimizuH.MorikawaS.HasebeF.MoritaK.IgarashiA.HatsuM.TakamizawaK.MiyamuraT.Identification and characterization of the RNA helicase activity of Japanese" exact="encephalitis" post="virus NS3 proteinFEBS Lett.46512000747810620709 VeeslerD.JohnsonJ.E.Virus maturationAnnu. Rev. Biophys.41201247349622404678 VlachJ.LipovJ.RumlovaM.VeverkaV.LangJ.SrbP.KnejzlikZ.PichovaI.HunterE.HrabalR.RumlT.D-retrovirus"/>
 <result pre="blocks intrahepatic virus spreading in humanized mice previously infected with" exact="hepatitis" post="B virusJ. Hepatol.585201386186723246506 VyseS.DesmondH.HuangP.H.Advances in mass spectrometry based strategies"/>
 <result pre="anti-coronavirus drug designSci. Rep.6226772016 WangX.TangS.SongX.RongL.Mathematical analysis of an HIV latent" exact="infection" post="model including both virus-to-cell infection and cell-to-cell transmissionJ. Biol."/>
 <result pre="analysis of an HIV latent infection model including both virus-to-cell" exact="infection" post="and cell-to-cell transmissionJ. Biol. Dyn.11sup2201745548327730851 WeissS.Measuring conformational dynamics of"/>
 <result pre="and proteolytic processingJ. Virol.79162005102681027716051820 XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic" exact="diarrhea" post="virus negatively regulates type I interferon pathway by acting"/>
 <result pre="XingY.ChenJ.TuJ.ZhangB.ChenX.ShiH.BakerS.C.FengL.ChenZ.The papain-like protease of porcine epidemic diarrhea virus negatively regulates" exact="type I" post="interferon pathway by acting as a viral deubiquitinaseJ. Gen."/>
 <result pre="negatively regulates type I interferon pathway by acting as a" exact="viral" post="deubiquitinaseJ. Gen. Virol.94720131554156723596270 XueL.WangW.-H.IliukA.HuL.GalanJ.A.YuS.HansM.GeahlenR.L.TaoW.A.Sensitive kinase assay linked with phosphoproteomics"/>
 <result pre="YanH.ZhongG.XuG.HeW.JingZ.GaoZ.HuangY.QiY.PengB.WangH.FuL.SongM.ChenP.GaoW.RenB.SunY.CaiT.FengX.SuiJ.LiW.Sodium taurocholate cotransporting polypeptide is a functional receptor for human" exact="hepatitis" post="B and D viruselife12012e0004923150796 YangL.MohrI.FoutsE.LimD.A.NohaileM.BotchanM.The E1 protein of bovine"/>
 <result pre="hepatitis B and D viruselife12012e0004923150796 YangL.MohrI.FoutsE.LimD.A.NohaileM.BotchanM.The E1 protein of bovine" exact="papilloma" post="virus 1 is an ATP-dependent DNA helicaseProc. Natl. Acad."/>
 <result pre="YangH.XieW.XueX.YangK.MaJ.LiangW.ZhaoQ.ZhouZ.PeiD.ZiebuhrJ.HilgenfeldR.YuenK.Y.WongL.GaoG.ChenS.ChenZ.MaD.BartlamM.RaoZ.Design of wide-spectrum inhibitors targeting coronavirus main proteasesPLoS Biol.3102005e32416128623 YilmazN.K.SwanstromR.SchifferC.A.Improving" exact="viral" post="protease inhibitors to counter drug resistanceTrends Microbiol.247201654755727090931 YonezawaA.CavroisM.GreeneW.C.Studies of"/>
 <result pre="ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human" exact="immunodeficiency" post="virus type 1 virions: involvement of cytoskeletal proteins and"/>
 <result pre="glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus" exact="type 1" post="virions: involvement of cytoskeletal proteins and enhancement by tumor"/>
 <result pre="type 1 virions: involvement of cytoskeletal proteins and enhancement by" exact="tumor" post="necrosis factor alphaJ. Virol.792200591892615613320 YoungrenJ.F.GoldfineI.D.PratleyR.E.Decreased muscle insulin receptor kinase"/>
 <result pre="proteins and enhancement by tumor necrosis factor alphaJ. Virol.792200591892615613320 YoungrenJ.F.GoldfineI.D.PratleyR.E.Decreased" exact="muscle" post="insulin receptor kinase correlates with insulin resistance in normoglycemic"/>
 <result pre="monitoring assay for kinasesAssay Drug Dev Technol76200956057220105026 ZengT.ZhangT.WeiW.LiZ.WuD.WangL.GuoJ.HeX.MaN.Compact, programmable, and" exact="stable" post="biofunctionalized upconversion nanoparticles prepared through peptide-mediated phase transfer for"/>
 <result pre="Infect. Dis.312017455327733043 ZhaoQ.LiS.XueF.ZouY.ChenC.BartlamM.RaoZ.Structure of the main protease from a global" exact="infectious" post="human coronavirus, HCoV-HKU1J. Virol.821720088647865518562531 ZhaoY.SohT.S.LimS.P.ChungK.Y.SwaminathanK.VasudevanS.G.ShiP.-Y.LescarJ.LuoD.Molecular basis for specific viral"/>
 <result pre="global infectious human coronavirus, HCoV-HKU1J. Virol.821720088647865518562531 ZhaoY.SohT.S.LimS.P.ChungK.Y.SwaminathanK.VasudevanS.G.ShiP.-Y.LescarJ.LuoD.Molecular basis for specific" exact="viral" post="RNA recognition and 2′-O-ribose methylation by the dengue virus"/>
 <result pre="function of the Zika virus full-length NS5 proteinNat. Commun.820171476228345656 ZhongJ.GastaminzaP.ChengG.KapadiaS.KatoT.BurtonD.R.WielandS.F.UprichardS.L.WakitaT.ChisariF.V.Robust" exact="hepatitis" post="C virus infection in vitroProc. Natl. Acad. Sci. U."/>
 <result pre="the Zika virus full-length NS5 proteinNat. Commun.820171476228345656 ZhongJ.GastaminzaP.ChengG.KapadiaS.KatoT.BurtonD.R.WielandS.F.UprichardS.L.WakitaT.ChisariF.V.Robust hepatitis C" exact="virus infection" post="in vitroProc. Natl. Acad. Sci. U. S. A.1022620059294929915939869 ZhouY.AgudeloJ.LuK.GoetzD.H.HansellE.ChenY.T.RoushW.R.McKerrowJ.CraikC.S.AmbergS.M.SimmonsG.Inhibitors"/>
 <result pre="Zika virus full-length NS5 proteinNat. Commun.820171476228345656 ZhongJ.GastaminzaP.ChengG.KapadiaS.KatoT.BurtonD.R.WielandS.F.UprichardS.L.WakitaT.ChisariF.V.Robust hepatitis C virus" exact="infection" post="in vitroProc. Natl. Acad. Sci. U. S. A.1022620059294929915939869 ZhouY.AgudeloJ.LuK.GoetzD.H.HansellE.ChenY.T.RoushW.R.McKerrowJ.CraikC.S.AmbergS.M.SimmonsG.Inhibitors"/>
 <result pre="conjugatesAnalyst139520141178118324445423 ZhouY.VedanthamP.LuK.AgudeloJ.CarrionR.NunneleyJ.W.BarnardD.PöhlmannS.McKerrowJ.H.RensloA.R.SimmonsG.Protease inhibitors targeting coronavirus and filovirus entryAntivir. Res.1162015768425666761 ZieglerC.M.EisenhauerP.BruceE.A.WeirM.E.KingB.R.KlausJ.P.KrementsovD.N.ShirleyD.J.BallifB.A.BottenJ.The" exact="lymphocytic choriomeningitis" post="virus matrix protein PPXY late domain drives the production"/>
</results>
